Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates. United States pharmaceuticals company Hims & Hers Health Inc. has announced that it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill, just two days after its launch,.